Aligos Therapeutics Inc.

NASDAQ: ALGS · Real-Time Price · USD
7.63
0.04 (0.59%)
At close: Aug 15, 2025, 11:03 AM

Aligos Therapeutics Revenue

Aligos Therapeutics reported an annual revenue of $3.94M, reflecting a -74.6% growth. For the quarter ending June 30, 2025, Aligos Therapeutics generated $965K in revenue.
Revenue (ttm)
3.94M
Revenue Growth
-74.6%
Price / Sales Ratio
63.27
Revenue / Employee
56.36K
Employees
70
Market Cap
46.93M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.